Cargando…
Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007249/ https://www.ncbi.nlm.nih.gov/pubmed/35418217 http://dx.doi.org/10.1038/s41422-022-00656-4 |
| _version_ | 1784686807621828608 |
|---|---|
| author | Li, Mengjiao Ye, Zi-Wei Tang, Kaiming Guo, Liang Bi, Wenwen Zhang, Yuyuan Tang, Yan-dong Rong, Guoguang Sawan, Mohamad Yin, Xin Sun, Ren Yuan, Shuofeng Dang, Bobo |
| author_facet | Li, Mengjiao Ye, Zi-Wei Tang, Kaiming Guo, Liang Bi, Wenwen Zhang, Yuyuan Tang, Yan-dong Rong, Guoguang Sawan, Mohamad Yin, Xin Sun, Ren Yuan, Shuofeng Dang, Bobo |
| author_sort | Li, Mengjiao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9007249 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90072492022-04-14 Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo Li, Mengjiao Ye, Zi-Wei Tang, Kaiming Guo, Liang Bi, Wenwen Zhang, Yuyuan Tang, Yan-dong Rong, Guoguang Sawan, Mohamad Yin, Xin Sun, Ren Yuan, Shuofeng Dang, Bobo Cell Res Letter to the Editor Springer Nature Singapore 2022-04-13 2022-06 /pmc/articles/PMC9007249/ /pubmed/35418217 http://dx.doi.org/10.1038/s41422-022-00656-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Li, Mengjiao Ye, Zi-Wei Tang, Kaiming Guo, Liang Bi, Wenwen Zhang, Yuyuan Tang, Yan-dong Rong, Guoguang Sawan, Mohamad Yin, Xin Sun, Ren Yuan, Shuofeng Dang, Bobo Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo |
| title | Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo |
| title_full | Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo |
| title_fullStr | Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo |
| title_full_unstemmed | Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo |
| title_short | Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo |
| title_sort | enhanced trimeric ace2 exhibits potent prophylactic and therapeutic efficacy against the sars-cov-2 delta and omicron variants in vivo |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007249/ https://www.ncbi.nlm.nih.gov/pubmed/35418217 http://dx.doi.org/10.1038/s41422-022-00656-4 |
| work_keys_str_mv | AT limengjiao enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT yeziwei enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT tangkaiming enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT guoliang enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT biwenwen enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT zhangyuyuan enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT tangyandong enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT rongguoguang enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT sawanmohamad enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT yinxin enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT sunren enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT yuanshuofeng enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo AT dangbobo enhancedtrimericace2exhibitspotentprophylacticandtherapeuticefficacyagainstthesarscov2deltaandomicronvariantsinvivo |